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PURPOSE. A lower retinal arteriolar-to-venular ratio (AVR) has
been suggested to reflect generalized arteriolar narrowing and
to predict the risk of cardiovascular diseases. The contribution
of the separate arteriolar and venular diameters to this AVR is
unknown. Thus, associations between retinal arteriolar and
venular diameters, and the AVR on the one hand and blood
pressure, atherosclerosis, inflammation markers, and choles-
terol levels on the other were examined in the Rotterdam
Study.
METHODS. In this cross-sectional population-based study, for
one eye of each subject (55 years; n  5674), retinal arterio-
lar and venular diameters (in micrometers) of the blood col-
umns were summed on digitized images. At baseline blood
pressures, cholesterol levels, and markers of atherosclerosis
and inflammation were also measured.
RESULTS. With increasing blood and pulse pressures, retinal
arteriolar and venular diameters and the AVR decreased signif-
icantly and linearly. Lower arteriolar diameters were associated
with increased carotid intima–media thickness. Larger venular
diameters were associated with higher carotid plaque score,
more aortic calcifications, lower ankle–arm index, higher leu-
kocyte count, higher erythrocyte sedimentation rate, higher
total serum cholesterol, lower HDL, higher waist-to-hip ratio,
and smoking. A lower AVR was related to increased carotid
intima–media thickness, higher carotid plaque score, higher
leukocyte count, lower HDL, higher body mass index, higher
waist-to-hip ratio, and smoking.
CONCLUSIONS. Because larger venular diameters are associated
with atherosclerosis, inflammation, and cholesterol levels, the
AVR does not depend only on generalized arteriolar narrowing
due to the association between smaller arteriolar diameters and
higher blood pressures. These data indicate that retinal venular
diameters are variable and may play their own independent
role in predicting cardiovascular disorders. (Invest Ophthal-
mol Vis Sci. 2004;45:2129–2134) DOI:10.1167/iovs.03-1390
Structural changes in the retinal vasculature have long beenrecognized as an important predictor of systemic hyperten-
sive damage and life prognosis.1,2 Different classifications
mainly depended on qualitative assessment of retinal vessels
using ophthalmoscopy, which has a poor reproducibility and
gauges arteriolar diameters against the venular ones.3
Recently, in the Atherosclerosis Risk in Communities
(ARIC) Study, a semiautomated system was developed to mea-
sure the vessel diameters on fundus photographs.4–6 The au-
thors attributed a lower arteriolar-to-venular ratio (AVR) to
generalized arteriolar narrowing and suggested that this ratio
may provide information that would predict incident cardio-
vascular diseases independently of known cardiovascular risk
factors.6–14 Compared with other retinal signs such as hemor-
rhages, focal arteriolar narrowing, and arteriovenous nicking,
the AVR was the more reliable and commonly used parameter
of vascular damage.6,8–11,15
It remains unclear, however, what exactly the separate
arteriolar and venular diameters contributed to the AVR and
what kind of vascular disease this ratio precisely reflects. Lim-
ited data have been published on the association between AVR
or retinal vessel diameters and blood pressure.6,11–13 Associa-
tions concerning AVR and atherosclerosis were inconclu-
sive.15,16 Currently, no data are available on the specific rela-
tionship between arteriolar or venular diameters and
atherosclerosis, inflammation markers, or cholesterol levels.




The present study was performed as part of the Rotterdam Study, a
population-based, cohort study on chronic and disabling diseases in
the elderly. A total of 7983 subjects 55 years of age and older living in
a district of Rotterdam agreed to participate in the study. Information
on the baseline study population has appeared in previous reports.17,18
Because the ophthalmic part became operational after the screening of
participants had started, a smaller number (n  6780) participated in
the ophthalmic examination.19 The study was conducted according to
the tenets of the Declaration of Helsinki, and the Medical Ethics
Committee of the Erasmus Medical Center approved the study proto-
col. A written informed consent was obtained from all participants.
Baseline interviews and examinations were performed from 1990 to
mid-1993.
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Retinal Vessel Measurements
After the eye examination at baseline, simultaneous stereoscopic fun-
dus color transparencies centered on the optic disc (pharmacological
mydriasis, 20°; Topcon Optical Co., Tokyo, Japan) were digitized with
a high-resolution scanner (model LS-4000; Nikon Corp., Tokyo, Ja-
pan).18 For each subject, the image with the best quality (left or right
eye) was analyzed with a semiautomated system (Retinal Analysis;
Optimate, Madison, WI; Department of Ophthalmology and Visual
Science, University of Wisconsin-Madison) by four trained graders
masked to the end points.4–6 We used the improved Parr-Hubbard
formula to compute the summary vessel measures.20 Because each eye
has a different magnification due to its optical system (lens, cornea) we
additionally adjusted this summary vessel measure for the refraction
and corneal curvature using Littmann’s formula to obtain absolute
measures.21 On one eye of each subject one sum value was calculated
for the arteriolar blood column diameter and one for the venular (in
micrometers), the AVR being the ratio of these. In a random subsample
of 100 subjects we found no differences between the right and left
eyes for the arteriolar and venular diameters.
Quality control sessions with a random subsample of 40 transpar-
encies gave the following Pearson’s correlation coefficients for inter-
grader agreement 0.67–0.80 (arteriolar diameter), 0.91–0.94 (venular
diameter), and 0.75–0.84 (AVR). For intragrader agreement these were
0.69–0.88, 0.90–0.95, and 0.72–0.90, respectively.
Blood Pressure, Atherosclerosis, Inflammation,
and Cholesterol
Blood pressures, ankle–arm index, intima–media thickness, carotid
artery plaques, and aortic atherosclerosis were measured as described
previously.22–24
Briefly, intima–media thickness of the common carotid artery was
assessed by ultrasonography, using a 7.5-MHz linear-array transducer
(ATL Ultra-Mark IV; Advanced Technology Laboratories, Bethel, West-
ern Australia). For the current analyses, the average of the mean
anterior and posterior intima–media thickness of both the left and the
right common carotid artery was used. Atherosclerotic plaques, as-
sessed by ultrasound at the bifurcation, common, and internal carotid
artery on both sides, were defined as focal thickening of the vessel wall
(of at least 1.5 times the average intima–media thickness) relative to
adjacent segments, with or without calcified components. The carotid
plaque score (range: 0–6) reflects the number of these locations with
plaques. Aortic atherosclerosis, defined as calcified deposits in the
abdominal aorta on lateral radiographic films of the lumbar spine, was
considered present when linear densities were seen in an area parallel
and anterior to the lumbar spine (L1–L4). The extent of calcification
was scored according to the length of the involved area (0, 0.5 to 1,
1 to 2.5, 2.5 to 5, 5 to 10, and 10 cm). All readers and
technicians were masked to all clinical information.
Leukocyte count was assessed in citrate plasma using a Coulter
Counter T540 (Coulter Electronics, Luton, UK). Blood was drawn
directly into tubes (Vacutainer; BD Biosciences, Heidelberg, Germany)
and erythrocyte sedimentation rate was read after 60 minutes. Non-
fasting serum total cholesterol and high-density lipoprotein (HDL)
concentrations were determined by an automated enzymatic proce-
dure.25 Information on smoking (categorized as current, former, or
never) and medication use was obtained during the home interview.
Alcohol consumption was assessed as part of a dietary interview.26
Study Sample
Of the 6780 participants in the ophthalmic part, 6436 persons under-
went optic disc photography. From these 762 subjects were excluded
because they had ungradable fundus transparencies on both eyes,
resulting in a cohort of 5674 subjects. Measurements on blood pres-
sure were missing in 91 participants, ankle–arm index in 547, intima–
media thickness in 918, carotid plaque score in 970, aortic calcifica-
tions in 1510, leukocyte count in 394, erythrocyte sedimentation rate
in 1543, total cholesterol in 44, HDL cholesterol in 53, body mass
index in 72, waist-to-hip ratio in 350, smoking in 65, and alcohol
consumption in 884. Restricted availability of technicians was the main
reason for missing data, which was independent of any subject char-
acteristics.
Statistical Analysis
Analysis of covariance (ANCOVA) was used to compare subjects with
gradable and ungradable transparencies and to analyze whether asso-
ciations were linear. If so, multiple linear regression models were used
to assess these cross-sectional relationships. We analyzed blood pres-
sures both per standard deviation and per 10-mm Hg increase. The
former was taken to compare the effect size between systolic and
diastolic blood pressures, and the latter to compare our results with
those of other studies.
All analyses were repeated after stratifying on subjects with dis-
eases known to affect venular width such as diabetes mellitus and
hypertension. All analyses were performed using SPSS (Windows ver.
11.0; SPSS Inc., Chicago, IL).
RESULTS
Table 1 shows the baseline characteristics of subjects with
gradable and ungradable transparencies. The means were: ar-
teriolar diameter, 146.9 m (range, 92.2–235.7; SD, 14.4),
venular diameter, 222.0 m (range, 135.1–313.6; SD, 20.9),
and AVR, 0.66 (range, 0.48 to 1.02; SD, 0.06).
Blood Pressures and Retinal Vessel Diameters
With increasing blood and pulse pressures, the arteriolar diam-
eters decreased linearly (Table 2). Figure 1 shows that the
relationship with the arteriolar diameters was strongest in the
youngest age category (per standard deviation increase in sys-
tolic blood pressure, 3.8 m; 95% CI, 4.7 to 2.8) and
became nonsignificant above age 80 years. With increasing
blood and pulse pressures, the venular diameters showed a
small decrease; when stratified by age, there seemed to be no
clear trend.
With increasing blood and pulse pressures, the AVR de-
creased linearly (Table 2). The relationship with AVR was
strongest in the age category 55 to 60 years (Fig. 1). Per
standard deviation increase in systolic blood pressure, AVR
decreased by 0.016 (95% CI, 0.012–0.019). Diastolic blood
pressure showed the same trends; hence, only systolic blood
pressure is presented in Figure 1.
Atherosclerosis and Retinal Vessel Diameters
The arteriolar diameters did not show an association with the
different markers of atherosclerosis except intima–media thick-
ness. After additional adjustment for blood pressure, this asso-
ciation became weaker (per standard deviation increase, 0.6
m; 95% CI, 1.0 to 0.1).
The venular diameters were linearly related to several mark-
ers of atherosclerosis. Larger venular diameters were associ-
ated with a lower ankle–arm index, higher carotid plaque
score, more aortic calcifications (borderline), and a nonsignifi-
cantly increased intima–media thickness. Additional adjust-
ment for blood pressure did not alter these associations. Strat-
ification on age did not show a trend between atherosclerosis
and retinal venular diameters.
A lower AVR was significantly related to a lower ankle–arm
index, increased intima–media thickness, and higher carotid
plaque score, but not to aortic calcifications (Table 2). After
additional adjustment for blood pressure, AVR was still associ-
ated with intima–media thickness (per standard deviation in-
crease,0.002; 95% CI,0.004 to0.001) and carotid plaque
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score (per plaque increase, 0.002; 95% CI, 0.003 to
0.001).
Inflammation Markers, Cholesterol Levels, and
Retinal Vessel Diameters
Higher leukocyte count, higher erythrocyte sedimentation
rate, lower serum HDL levels, higher total serum cholesterol,
higher waist-to-hip ratio, and smoking were related to larger
venular diameters and to a lesser extent to larger arteriolar
diameters, thus resulting in a lower AVR (Table 3).
These analyses were repeated using models in which the
cardiovascular variables were categorized. Because all relation-
ships were linear in these analyses, only the linear models are
presented. Stratification on subjects with and without hyper-




Subjects (n) 5674 762
Age (y) 68.0 (8.20) 75.7 (10.10) 7.8 (7.10 to 8.40)§
Gender (% female) 59.0 63.0 0.1 (3.80 to 4.00)
Institutionalized (%) 3.6 22.0 9.9 (8.30 to 11.60)§
Diabetes mellitus (%) 10.0 14.0 0.9 (1.40 to 3.30)
Systolic blood pressure (mm Hg) 138.5 (22.10) 145.2 (24.00) 1.5 (0.20 to 3.30)
Diastolic blood pressure (mm Hg) 73.7 (11.40) 74.2 (12.80) 1.4 (0.50 to 2.30)§
Pulse pressure (mm Hg) 64.8 (17.70) 71.0 (19.70) 0.1 (1.20 to 1.40)
Ankle–arm index 1.07 (0.22) 0.97 (0.28) 0.03 (0.05 to 0.02)§
Carotid intima–media thickness (mm) 0.79 (0.15) 0.86 (0.19) 0.02 (0.01 to 0.03)§
Aorta calcification  5 cm (%) 11.1 17.6 2.1 (1.20 to 5.40)
Carotid plaques  4 (%) 16.1 24.0 1.5 (1.70 to 4.70)
Leukocyte count (109/L) 6.7 (1.90) 6.8 (3.00) 0.1 (0.10 to 0.20)
Erythrocyte sedimentation rate 12.9 (10.70) 16.2 (14.40) 1.3 (0.20 to 2.30)§
Total serum cholesterol (mmol/L) 6.63 (1.21) 6.53 (1.30) 0.01 (0.10 to 0.10)
Serum HDL cholesterol (mmol/L) 1.35 (0.36) 1.34 (0.36) 0.00 (0.02 to 0.03)
Body mass index (kg/m2) 26.3 (3.68) 26.0 (3.69) 0.44 (0.73 to 0.14)§
Waist-to-hip ratio 0.90 (0.09) 0.91 (0.09) 0.00 (0.01 to 0.01)
Smoking (%)
Current 23.6 18.7 0.4 (2.90 to 3.70)
Former 42.9 36.8 3.7 (7.40 to 1.90)
Alcohol consumption (%)
10 g/d‡ 45.0 41.9 3.3 (8.10 to 1.50)
10–20 g/d 15.4 13.0 1.3 (4.80 to 2.20)
20 g/d 19.5 19.3 1.0 (2.70 to 4.70)
Data are presented as unadjusted means (SD) or percentages.
* Subjects with a gradable fundus transparency on at least one eye.
† Age and gender adjusted if applicable.
‡ 10 grams is on average equal to 1 drink.
§ Significant (P  0.05).
TABLE 2. Age- and Gender-Adjusted Difference in Retinal Vessel Diameters with Increasing Blood Pressure Levels both per SD and per 10-mm










Per SD increase 5583 2.4 (2.8 to 2.0)* 1.0 (1.6 to 0.5)* 0.008 (0.009 to 0.006)*
Per 10-mm Hg increase 1.1 (1.3 to 0.9)* 0.5 (0.7 to 0.2)* 0.0035 (0.004 to 0.003)*
Diastolic Blood Pressure:
Per SD increase 5583 2.4 (2.8 to 2.1)* 0.8 (1.3 to 0.2)* 0.009 (0.010 to 0.007)*
Per 10-mm Hg increase 2.1 (2.5 to 1.8)* 0.7 (1.1 to 0.2)* 0.008 (0.009 to 0.006)*
Pulse Pressure:
Per SD increase 5583 1.5 (1.9 to 1.1)* 0.8 (1.4 to 0.3)* 0.004 (0.006 to 0.003)*
Per 10-mm Hg increase 0.8 (1.1 to 0.6)* 0.5 (0.8 to 0.1)* 0.002 (0.003 to 0.001)*
Markers of sub-clinical atherosclerosis
Carotid Intima-media thickness
Per SD increase 4756 0.9 (1.4 to 0.5)* 0.2 (0.8 to 0.5) 0.004 (0.005 to 0.002)*
Carotid plaque-score
Per plaque increase 4704 0.2 (0.5 to 0.1) 0.4 (0.1 to 0.8)* 0.002 (0.003 to 0.001)*
Ankle–arm index
Per SD decrease 5127 0.4 (0.0 to 0.8) 1.3 (0.7 to 1.9)* 0.002 (0.0004 to 0.004)*
Aorta calcification
Per category increase 4164 0.03 (0.3 to 0.4) 0.4 (0.1 to 0.8) 0.001 (0.002 to 0.001)
95% CI is in parentheses.
* Significant (P  0.05).
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tension did not significantly alter any of the above-mentioned
results. The results were again the same after stratification
according to the presence of diabetes mellitus. However, in
subjects with diabetes mellitus the point estimates for these
relationships were less stable with wider confidence intervals
because only 10% of the population had diabetes mellitus at
baseline.
DISCUSSION
These results show that higher blood and pulse pressures were
related to lower arteriolar diameters. More severe atheroscle-
rosis, as measured by the ankle–arm index, aortic calcifications
and carotid plaque score, higher leukocyte count, higher eryth-
rocyte sedimentation rate, higher total cholesterol, lower HDL
levels, higher waist-to-hip ratio, or smoking were related to
larger venular diameters, with the overall effect being a lower
AVR.
For proper interpretation some methodological issues war-
rant consideration. The excluded subjects were on average
older and more often institutionalized. This group probably
contained more subjects with physical or mental disabilities or
lens opacities that contributed to the poor quality of the trans-
parencies. However, there were only small differences in car-
diovascular risk factors between the two groups, suggesting a
limited role for selection bias.
The cross-sectional setting prevented inferring causality or a
chronological order of events. Photographs were not taken
synchronized on the cardiac cycle, and thus there may be
variation in vessel diameter due to pulsatility. A variation of 2%
to 17% in vessel diameter has been described.27 However,
because photography was independent of any subject charac-
teristics, this variation will have caused random misclassifica-
tion.
Strengths of this study include its population-based design,
data collection within a short time span, and the detailed
measurement of vessel diameters on 20° stereoscopic fundus
transparencies (leading to higher magnification) obtained after
pharmacological mydriasis. Both the ARIC and the Cardiovas-
cular Health studies (CHS) used 45° photographs without phar-
macological mydriasis, whereas the Blue Mountains Eye Study
used 30° photographs through dilated pupils.6,15,13 Further-
more, ours seems to be the first study that used the improved
Parr-Hubbard formulas and Littmann’s correction to approxi-
mate absolute intraluminal diameters.20,21
Blood Pressure and Retinal Vessel Diameters
When analyzed separately, the impact of blood pressure was
more prominent in younger subjects and more in arterioles
than venules, as expected. The decrease in arteriolar diameters
not only reflects vasoconstriction but also intimal thickening,
medial hyperplasia, hyalinization, and sclerosis.28,29 We found
smaller decrease in arteriolar diameter (1.1 and 2.1 m per
10-mm Hg increase in systolic and diastolic blood pressure,
respectively) than reported (1.9 and 4.3 m).13 Apart from the
mentioned differences in grading and measuring techniques,
this smaller decrease could be explained by the older age
distribution of our cohort (55–99 years) versus that in the ARIC
Study (48–76 years) and the Blue Mountains Study (49 years,
only 8% above age 80 years).6,13 In the older age groups, the
vessels become progressively rigid and lose their ability to
react adequately to blood pressure changes.30,31
The association between venular diameter and blood pres-
sure was weak, and, when stratified by age, there was no trend.
In our oldest age category, the estimate may be unstable due to
the low number of subjects.
Atherosclerosis and Retinal Vessel Diameters
There was no relationship between the arteriolar diameters
and markers of atherosclerosis, except for intima–media thick-
ness. Apart from being a marker of atherosclerosis, intima–
media thickness may indicate a response of the artery wall to
changes in shear and tensile stress due to hypertension.32 This
is also supported by our data, because after additional adjust-
ment for blood pressure this association became weaker.
We did find a relationship between atherosclerosis and
larger venular diameters. A clear pathophysiological explana-
tion for this association is lacking. It is known that in diabetic
retinopathy, the retinal venules become wider.33 Other exam-
ples of venular dilatation are patients with central retinal vein
occlusion, carotid artery narrowing leading to so-called venous
FIGURE 1. The relationship between blood pressure and retinal vessel
measurements per 5-year age categories. Age category 90–95 years was
excluded because of the low number of subjects (n  40).
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stasis retinopathy, or deep venous thrombosis in the legs, who
also have more often atherosclerosis.34,35 It has been suggested
that hyperlipidemia, platelet activation, and blood coagulation
are involved in the development of both atherosclerosis and
venous thrombosis.35 Whether atherosclerosis induces venular
changes, both share common risk factors, or they occur inde-
pendently of each other still has to be elucidated.
In the CHS study, atherosclerosis, as measured by ankle–
arm index, carotid plaques, and intima–media thickness was,
contrary to our findings, not related to AVR.15 Selection bias
may have occurred, because they performed carotid ultra-
sonography 5 years before fundus photography.15 In the ARIC
study, however, a lower AVR was related to more carotid
plaques,16 and in our study the relationship with AVR persisted
for intima–media thickness and carotid plaque score after ad-
justing for blood pressures. The relationship between markers
of atherosclerosis and AVR is mainly driven by larger venular
diameters.
Inflammation Markers, Cholesterol Levels, and
Retinal Vessel Diameters
Higher leukocyte count, higher erythrocyte sedimentation
rate, lower HDL levels, higher waist-to-hip ratio, and smoking
were associated with larger arteriolar and even more strongly
with larger venular diameters. Because inflammation also plays
an important part in atherosclerosis, vessel widening in these
conditions may be due to similar mechanisms. We hypothesize
that disruption of the endothelial surface layer (ESL) may un-
derlie the apparent vessel widening. The endothelial surface of
all vessels is coated with a matrix of proteoglycans and gly-
coproteins. This layer (glycocalyx) is directly bound to the
plasma-membrane.36,37 An immobile plasma layer consisting of
soluble plasma proteins including glycosaminoglycans is at-
tached to this glycocalyx. Together, these layers are known as
the ESL, with a thickness ranging from 0.5 m to more than 1.0
m.36 The presence of the ESL may influence several physio-
logical functions of the vessels including flow resistance, bar-
rier function, leukocyte adhesion, coagulation, and angiogen-
esis.36 Damage to the ESL seems to be the earliest detectable
injury to the vascular wall in atherosclerosis.37 Free radicals, as
produced by oxidized low-density lipoproteins or activated
leukocytes, can disrupt this surface.37 It could be that the
increase in intraluminal diameter we observed with increasing
severity of atherosclerosis or inflammation partly reflects a
diminishing ESL.
That higher leukocyte count, lower HDL levels, higher body
mass index, higher waist-to-hip ratio and smoking were related
to a lower AVR supports the suggestion that the AVR is also a
marker of inflammation and endothelial dysfunction.16
CONCLUSIONS
Our data confirmed that elevated blood pressures were asso-
ciated with smaller arteriolar diameters, but revealed that
larger venular diameters were related to atherosclerosis, in-
flammation, and cholesterol levels. Hence, the idea that the
AVR overall reflects generalized arteriolar narrowing should be
reevaluated by taking into account the separate arteriolar and
venular diameters. These data indicate that the venular diame-
ters do not remain constant in different pathologic conditions
and may play their own independent role in predicting cardio-
vascular disease. In future research, more attention should be
paid to the role of venules in vascular disease.
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